craft-sa-dev Home  

PMC:1064854 / 64121-64662 JSONTXT 7 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T38945 0-7 NN denotes Insulin
T38947 8-11 CC denotes and
T38948 12-19 NN denotes glucose
T38946 20-29 NN denotes tolerance
T38949 30-35 NNS denotes tests
T38950 35-105 sentence denotes Glucose and Insulin tolerance tests were performed as described [35].
T38951 36-43 NN denotes Glucose
T38953 44-47 CC denotes and
T38954 48-55 NN denotes Insulin
T38952 56-65 NN denotes tolerance
T38955 66-71 NNS denotes tests
T38957 72-76 VBD denotes were
T38956 77-86 VBN denotes performed
T38958 87-89 IN denotes as
T38959 90-99 VBN denotes described
T38960 100-101 -LRB- denotes [
T38961 101-103 CD denotes 35
T38962 103-104 -RRB- denotes ]
T38963 104-105 . denotes .
T38964 105-170 sentence denotes Prior to studies, mice were fasted overnight (GTT) or 6 h (ITT).
T38965 106-111 JJ denotes Prior
T38966 112-114 IN denotes to
T38968 115-122 NNS denotes studies
T38969 122-124 , denotes ,
T38970 124-128 NNS denotes mice
T38971 129-133 VBD denotes were
T38967 134-140 VBN denotes fasted
T38972 141-150 RB denotes overnight
T38974 151-152 -LRB- denotes (
T38975 152-155 NN denotes GTT
T38976 155-156 -RRB- denotes )
T38977 157-159 CC denotes or
T38978 160-161 CD denotes 6
T38973 162-163 NN denotes h
T38979 164-165 -LRB- denotes (
T38980 165-168 NN denotes ITT
T38981 168-169 -RRB- denotes )
T38982 169-170 . denotes .
T38983 170-248 sentence denotes In GTT studies, mice were injected with a 10% solution of D-glucose (1 g/kg).
T38984 171-173 IN denotes In
T38986 174-177 NN denotes GTT
T38987 178-185 NNS denotes studies
T38988 185-187 , denotes ,
T38989 187-191 NNS denotes mice
T38990 192-196 VBD denotes were
T38985 197-205 VBN denotes injected
T38991 206-210 IN denotes with
T38992 211-212 DT denotes a
T38994 213-215 CD denotes 10
T38995 215-216 NN denotes %
T38993 217-225 NN denotes solution
T38996 226-228 IN denotes of
T38997 229-230 NN denotes D
T38999 230-231 HYPH denotes -
T38998 231-238 NN denotes glucose
T39000 239-240 -LRB- denotes (
T39002 240-241 CD denotes 1
T39001 242-243 NN denotes g
T39003 243-244 SYM denotes /
T39004 244-246 NN denotes kg
T39005 246-247 -RRB- denotes )
T39006 247-248 . denotes .
T39007 248-405 sentence denotes For ITT, mice received an IP injection of human regular insulin (Eli Lilly, Indianapolis, Indiana, United States) at a dose of 0.75 units/kg of body weight.
T39008 249-252 IN denotes For
T39010 253-256 NN denotes ITT
T39011 256-258 , denotes ,
T39012 258-262 NNS denotes mice
T39009 263-271 VBD denotes received
T39013 272-274 DT denotes an
T39015 275-277 NN denotes IP
T39014 278-287 NN denotes injection
T39016 288-290 IN denotes of
T39017 291-296 JJ denotes human
T39019 297-304 JJ denotes regular
T39018 305-312 NN denotes insulin
T39020 313-314 -LRB- denotes (
T39022 314-317 NNP denotes Eli
T39021 318-323 NNP denotes Lilly
T39023 323-325 , denotes ,
T39024 325-337 NNP denotes Indianapolis
T39025 337-339 , denotes ,
T39026 339-346 NNP denotes Indiana
T39027 346-348 , denotes ,
T39028 348-354 NNP denotes United
T39029 355-361 NNP denotes States
T39030 361-362 -RRB- denotes )
T39031 363-365 IN denotes at
T39032 366-367 DT denotes a
T39033 368-372 NN denotes dose
T39034 373-375 IN denotes of
T39035 376-380 CD denotes 0.75
T39036 381-386 NNS denotes units
T39037 386-387 SYM denotes /
T39038 387-389 NN denotes kg
T39039 390-392 IN denotes of
T39040 393-397 NN denotes body
T39041 398-404 NN denotes weight
T39042 404-405 . denotes .
T39043 405-541 sentence denotes Tail blood glucose was determined at 0, 30, 60, and 120 min after challenge using a B-GLUCOSE Analyzer (Hemacue AB, Angelholm, Sweden).
T39044 406-410 NN denotes Tail
T39046 411-416 NN denotes blood
T39045 417-424 NN denotes glucose
T39048 425-428 VBD denotes was
T39047 429-439 VBN denotes determined
T39049 440-442 IN denotes at
T39050 443-444 CD denotes 0
T39052 444-446 , denotes ,
T39053 446-448 CD denotes 30
T39054 448-450 , denotes ,
T39055 450-452 CD denotes 60
T39056 452-454 , denotes ,
T39057 454-457 CC denotes and
T39058 458-461 CD denotes 120
T39051 462-465 NN denotes min
T39059 466-471 IN denotes after
T39060 472-481 NN denotes challenge
T39061 482-487 VBG denotes using
T39062 488-489 DT denotes a
T39064 490-491 NNP denotes B
T39066 491-492 HYPH denotes -
T39065 492-499 NNP denotes GLUCOSE
T39063 500-508 NNP denotes Analyzer
T39067 509-510 -LRB- denotes (
T39069 510-517 NNP denotes Hemacue
T39068 518-520 NNP denotes AB
T39070 520-522 , denotes ,
T39071 522-531 NNP denotes Angelholm
T39072 531-533 , denotes ,
T39073 533-539 NNP denotes Sweden
T39074 539-540 -RRB- denotes )
T39075 540-541 . denotes .
R10000 T38960 T38961 punct [,35
R10001 T38961 T38959 parataxis 35,described
R10002 T38962 T38961 punct ],35
R10003 T38963 T38956 punct .,performed
R10004 T38965 T38966 amod Prior,to
R10005 T38966 T38967 prep to,fasted
R10006 T38968 T38966 pobj studies,to
R10007 T38969 T38967 punct ", ",fasted
R10008 T38970 T38967 nsubjpass mice,fasted
R10009 T38971 T38967 auxpass were,fasted
R10010 T38972 T38973 advmod overnight,h
R10011 T38973 T38967 npadvmod h,fasted
R10012 T38974 T38975 punct (,GTT
R10013 T38975 T38972 parataxis GTT,overnight
R10014 T38976 T38975 punct ),GTT
R10015 T38977 T38973 cc or,h
R10016 T38978 T38973 nummod 6,h
R10017 T38979 T38980 punct (,ITT
R10018 T38980 T38973 parataxis ITT,h
R10019 T38981 T38980 punct ),ITT
R10020 T38982 T38967 punct .,fasted
R10021 T38984 T38985 prep In,injected
R10022 T38986 T38987 compound GTT,studies
R10023 T38987 T38984 pobj studies,In
R10024 T38988 T38985 punct ", ",injected
R10025 T38989 T38985 nsubjpass mice,injected
R10026 T38990 T38985 auxpass were,injected
R10027 T38991 T38985 prep with,injected
R10028 T38992 T38993 det a,solution
R10029 T38993 T38991 pobj solution,with
R10030 T38994 T38995 nummod 10,%
R10031 T38995 T38993 compound %,solution
R10032 T38996 T38993 prep of,solution
R10033 T38997 T38998 compound D,glucose
R10034 T38998 T38996 pobj glucose,of
R10035 T38999 T38998 punct -,glucose
R10036 T39000 T39001 punct (,g
R10037 T39001 T38998 parataxis g,glucose
R10038 T39002 T39001 nummod 1,g
R10039 T39003 T39004 punct /,kg
R10040 T39004 T39001 prep kg,g
R10041 T39005 T39001 punct ),g
R10042 T39006 T38985 punct .,injected
R10043 T39008 T39009 prep For,received
R10044 T39010 T39008 pobj ITT,For
R10045 T39011 T39009 punct ", ",received
R10046 T39012 T39009 nsubj mice,received
R10047 T39013 T39014 det an,injection
R10048 T39014 T39009 dobj injection,received
R10049 T39015 T39014 compound IP,injection
R10050 T39016 T39014 prep of,injection
R10051 T39017 T39018 amod human,insulin
R10052 T39018 T39016 pobj insulin,of
R10053 T39019 T39018 amod regular,insulin
R10054 T39020 T39021 punct (,Lilly
R10055 T39021 T39014 parataxis Lilly,injection
R10056 T39022 T39021 compound Eli,Lilly
R10057 T39023 T39021 punct ", ",Lilly
R10058 T39024 T39021 npadvmod Indianapolis,Lilly
R10059 T39025 T39021 punct ", ",Lilly
R10060 T39026 T39021 npadvmod Indiana,Lilly
R10061 T39027 T39021 punct ", ",Lilly
R10062 T39028 T39029 compound United,States
R10063 T39029 T39021 npadvmod States,Lilly
R10064 T39030 T39021 punct ),Lilly
R10065 T39031 T39009 prep at,received
R10066 T39032 T39033 det a,dose
R10067 T39033 T39031 pobj dose,at
R10068 T39034 T39033 prep of,dose
R10069 T39035 T39036 nummod 0.75,units
R10070 T39036 T39034 pobj units,of
R10071 T39037 T39038 punct /,kg
R10072 T39038 T39036 prep kg,units
R10073 T39039 T39038 prep of,kg
R10074 T39040 T39041 compound body,weight
R10075 T39041 T39039 pobj weight,of
R10076 T39042 T39009 punct .,received
R10077 T39044 T39045 compound Tail,glucose
R10078 T39045 T39047 nsubjpass glucose,determined
R10079 T39046 T39045 compound blood,glucose
R10080 T39048 T39047 auxpass was,determined
R10081 T39049 T39047 prep at,determined
R10082 T39050 T39051 nummod 0,min
R10083 T39051 T39049 pobj min,at
R10084 T39052 T39050 punct ", ",0
R10085 T39053 T39050 conj 30,0
R10086 T39054 T39053 punct ", ",30
R10087 T39055 T39053 conj 60,30
R10088 T39056 T39055 punct ", ",60
R10089 T39057 T39055 cc and,60
R10090 T39058 T39055 conj 120,60
R10091 T39059 T39051 prep after,min
R10092 T39060 T39059 pobj challenge,after
R10093 T39061 T39047 advcl using,determined
R10094 T39062 T39063 det a,Analyzer
R10095 T39063 T39061 dobj Analyzer,using
R10096 T39064 T39065 compound B,GLUCOSE
R10097 T39065 T39063 compound GLUCOSE,Analyzer
R10098 T39066 T39065 punct -,GLUCOSE
R10099 T39067 T39068 punct (,AB
R10100 T39068 T39061 parataxis AB,using
R10101 T39069 T39068 compound Hemacue,AB
R10102 T39070 T39068 punct ", ",AB
R10103 T39071 T39068 npadvmod Angelholm,AB
R10104 T39072 T39068 punct ", ",AB
R10105 T39073 T39068 npadvmod Sweden,AB
R10106 T39074 T39068 punct ),AB
R10107 T39075 T39047 punct .,determined
R9988 T38945 T38946 nmod Insulin,tolerance
R9989 T38946 T38949 compound tolerance,tests
R9990 T38947 T38945 cc and,Insulin
R9991 T38948 T38945 conj glucose,Insulin
R9992 T38951 T38952 nmod Glucose,tolerance
R9993 T38952 T38955 compound tolerance,tests
R9994 T38953 T38951 cc and,Glucose
R9995 T38954 T38951 conj Insulin,Glucose
R9996 T38955 T38956 nsubjpass tests,performed
R9997 T38957 T38956 auxpass were,performed
R9998 T38958 T38959 mark as,described
R9999 T38959 T38956 advcl described,performed